We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




High Density Microarrays Profile Noncoding RNAs

By LabMedica International staff writers
Posted on 18 Nov 2008
The first high-density microarray has been launched for the profiling of noncoding ribonucleic acids (RNAs). More...


The NCode human and mouse noncoding RNA microarrays consist of both noncoding RNA and messenger RNA (mRNA) content on the same array. The arrays are designed by Invitrogen Corp. (Carlsbad, CA, USA) and then manufactured by Agilent Technologies, Inc. (Santa Clara, CA, USA), using the company's proprietary SurePrint technology. Invitrogen will market and distribute the product.

Transcription, or the synthesis of RNA as directed by DNA, involves not only messenger RNA (mRNA) corresponding to the genes that are translated into proteins, but also tens of thousands of long non-protein-coding RNAs. The noncoding RNAs appear to comprise a vast hidden layer of genetic programming implicated in development and disease pathways in mammals.

"Noncoding RNA transcripts play a variety of roles in a cell, ranging from simple housekeeping to complex regulatory functions, and evidence is mounting that their expression is perturbed in many cancers,” said John Mattick, Ph.D., professor of molecular biology at the University of Queensland (Australia)

"When we talked to scientists about their interest in studying noncoding RNA, many told us they wanted a microarray that consisted of both mRNA and noncoding RNA content, which would help them elucidate the function of specific noncoding RNAs in relation to known pathways of gene expression,” said Amy Butler, vice president of Gene Expression Profiling for Invitrogen. "We answered with an array-based solution, exclusive to Invitrogen that has tens of thousands of coding and noncoding sequences which could answer multiple scientific questions with a single experiment.”

Invitrogen provides products and services that support academic and government institutions, and pharmaceutical and biotech companies worldwide in their efforts to improve the human condition.

Agilent Technologies is a measurement company and a technology leader in communications, electronics, life sciences, and chemical analysis.

Related Links:
Invitrogen
Agilent Technologies
University of Queensland




Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Verification Panels for Assay Development & QC
Seroconversion Panels
POCT Fluorescent Immunoassay Analyzer
FIA Go
Gold Member
Parainfluenza Virus Test
PARAINFLUENZA ELISA
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.